Table 2 GO enrichment analysis of some ischemic stroke-related lncRNAs
LncRNA | GO category | GO term |
|---|---|---|
MEG3 | Biological process | DEVELOPMENT: lung development; embryo development; post-embryonic development; skeletal muscle development; liver development; multicellular organism growth; determination of adult lifespan. |
| Â | Â | VASCULAR: angiogenesis; regulation of vascular endothelial growth factor receptor signaling pathway; |
| Â | Â | GENE REGULATION: RNA folding; DNA-templated transcription; DNA biosynthesis; hypomethylation of CpG island; DNA methylation; genetic imprinting. |
| Â | Â | INFLAMMATION: Notch signaling pathway; SMAD protein signal transduction. |
| Â | Â | CELL GROWTH: cell differentiation; negative regulation of cell proliferation. |
| Â | Â | OTHERS: axon guidance; gonadotropin secretion; epithelial tube morphogenesis. |
| Â | Molecular function | Transcription co-activator activity. |
| Â | Cellular component | Nucleus, cytoplasm. |
MALAT1 | Biological process | Nuclear speck organization; mRNA splicing; synapse organization; myoblast proliferation. |
| Â | Molecular function | Protein binding. |
| Â | Cellular component | Nuclear body, nuclear speck. |
H19 | Biological process | GENE REGULATION: DNA methylation; gene expression; genetic imprinting. |
| Â | Â | CELL GROWTH: regulation of multicellular organism growth; regulation of cell proliferation. |
| Â | Cellular component | Polysome, cytoplasm. |
TUG1 | Biological process | Photoreceptor cell development. |